Literature DB >> 20648463

[Annual economic cost of informal care in Alzheimer's disease].

Oriol Turró-Garriga1, Secundino López-Pousa, Joan Vilalta-Franch, Antoni Turon-Estrada, Imma Pericot-Nierga, Manuela Lozano-Gallego, Marta Hernández-Ferràndiz, Olga Soler-Cors, Xènia Planas-Pujol, Silvia Monserrat-Vila, Josep Garre-Olmo.   

Abstract

INTRODUCTION: The indirect cost associated with the care of patients with Alzheimer's disease is taken on primarily by the family. AIM: To describe the cost associated with time dedication, its annual evolution, associated characteristics and related caregiver burden. SUBJECTS AND METHODS: Non-institutionalized patients diagnosed with Alzheimer's disease who are managed on an out-patient basis in a diagnosis unit and their primary caregivers. Prospective and observational study conducted over 12 months. The patient's clinical features were assessed using the Cambrigde Cognitive Examination Revised for cognitive capacity, the Disability Assessment in Dementia for functional capacity and the Neuropsychiatric Inventory for non-cognitive disorders. Sociodemographic data were collected by means of the Cambridge Examination for Mental Disorders of the Elderly Revised. The caregiver's dedication, sociodemographic characteristics and burden (by means of the Zarit interview) were recorded.
RESULTS: Sample comprised of 169 patients and 169 caregivers. The cost at baseline was 6364.8 euro/year, and was mainly associated with support in instrumental activities. At 12 months, an overall increase of 29% was observed (1846.8 euro/year). Cost increase was associated with physical (F = 25.2; df = 1; p < 0.001) and cognitive (F = 8.5; df = 1; p = 0.004) disability, patient age (F = 9.2; df = 1; p = 0.003) and with whether the caregiver was the only caregiver or not (F = 20.4; df = 1; p < 0.001). The cost of care explained 6.7% of the total variance of the burden perceived by caregivers.
CONCLUSIONS: Care has a mean indirect cost of 6364.2 euro/year, with an annual increase of 29% that was associated with physical and cognitive disability, patient age and having one single caregiver.

Entities:  

Mesh:

Year:  2010        PMID: 20648463

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  [When should specific pharmacological treatment be stopped in Alzheimer's?].

Authors:  Gabriel Coll-de-Tuero; Secundino López-Pousa; Joan Vilalta-Franch
Journal:  Aten Primaria       Date:  2011-10-05       Impact factor: 1.137

Review 2.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

Review 3.  Cost of disorders of the brain in Spain.

Authors:  Oleguer Parés-Badell; Gabriela Barbaglia; Petra Jerinic; Anders Gustavsson; Luis Salvador-Carulla; Jordi Alonso
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

4.  Diseases Costs and Impact of the Caring Role on Informal Carers of Children with Neuromuscular Disease.

Authors:  Alicia Aurora Rodríguez; Óscar Martínez; Imanol Amayra; Juan Francisco López-Paz; Mohammad Al-Rashaida; Esther Lázaro; Patricia Caballero; Manuel Pérez; Sarah Berrocoso; Maitane García; Paula María Luna; Paula Pérez-Núñez; Nicole Passi
Journal:  Int J Environ Res Public Health       Date:  2021-03-15       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.